Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') is excited to announce that the groundbreaking results of the Phase III clinical study (HARMONi-2/AK112-303) of its first-in-class PD-1/VEGF bispecific ...

Breast cancer patients who underwent postmastectomy breast reconstruction had lower sexual well-being scores compared with ...

Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...

The following is a summary of “5-fluorouracil 5% cream for squamous cell carcinoma in situ: Factors impacting treatment ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...

Isabella Strahan shared what she would have done differently during her brain cancer treatment eight months after announcing she was cancer-free.

The longtime local news meteorologist has been temporarily absent from broadcasts as he manages his health, but he’ll be back ...

The US Food and Drug Administration (FDA) has approved BeiGene’s Tevimbra (tislelizumab-jsgr) along with platinum-containing ...

In a small study in a community oncology practice, more than 60% of patients with advanced squamous cell skin cancer treated ...

ALX Oncology is laying off 30% of its workforce as the biotech seeks to channel its cash into further trials of its CD47 ...

"We are excited with the rapid completion of enrollment of the third safety cohort," said Robert Bitterman, CEO of Phio Pharmaceuticals. "We look forward to rapidly advancing the study to bring an ...

The US Food and Drug Administration has approved tislelizumab (Tevimbra, BeiGene), in combination with platinum-containing ...